Behrad Derakhshan insider trades
Open-market stock purchases and sales by Behrad Derakhshan, Chief Business Officer at Edgewise Therapeutics, Inc, from SEC Form 4 filings since Aug 17, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc | Sold | $95.1K |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc | Sold | $13.5K |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc | Bought (not open market) | — |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc | Sold | $6.7K |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc | Sold | $108K |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc | Bought (not open market) | — |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc | Bought (not open market) | — |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc | Bought (not open market) | — |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- EWTX Edgewise Therapeutics, Inc: 13 sales, last Aug 12, 2026